COSCIENS Biopharma Inc. (CSCI : TSX)
Common Stock
$3.01
CAD
+0.00 (%)
Last updated: 2026-06-22
CSCI
COSCIENS Biopharma Inc.
WealthAwesomePerformance
1 Day
+0.00%
1 Week
-4.44%
1 Month
+18.04%
YTD
+3.79%
Key Statistics
Market Cap
$9.58M
52W High
$6.00
52W Low
$1.10
P/E Ratio
-
50 Day MA
$2.71
200 Day MA
$2.87
Beta
1.93
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/22/2026 | $3.00 | $3.10 | $3.00 | $3.01 | $3.01 | 852 |
| 6/19/2026 | $3.18 | $3.28 | $3.01 | $3.01 | $3.01 | 2,497 |
| 6/18/2026 | $3.02 | $3.20 | $3.02 | $3.19 | $3.19 | 6,836 |
| 6/17/2026 | $3.12 | $3.25 | $3.11 | $3.24 | $3.24 | 2,964 |
| 6/16/2026 | $3.24 | $3.24 | $2.98 | $3.02 | $3.02 | 1,293 |
| 6/15/2026 | $2.79 | $3.20 | $2.79 | $3.15 | $3.15 | 14,845 |
| 6/12/2026 | $2.60 | $2.87 | $2.60 | $2.86 | $2.86 | 1,800 |
| 6/11/2026 | $2.82 | $2.82 | $2.82 | $2.82 | $2.82 | 1,094 |
| 6/10/2026 | $2.85 | $2.85 | $2.81 | $2.81 | $2.81 | 448 |
| 6/9/2026 | $2.85 | $3.00 | $2.66 | $2.90 | $2.90 | 4,490 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
79.9%
Annualized
90-Day Vol
151.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$3.60
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.19 | C$2.42 – C$4.21 |
| 60 trading days | C$3.39 | C$2.30 – C$5.01 |
| 90 trading days | C$3.60 | C$2.23 – C$5.80 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Financials
- Revenue (TTM)
- $8.00M
- EBITDA
- $-7.57M
- Profit Margin
- 50.68%
- ROE (TTM)
- -61.79%
- EPS (Diluted)
- -3.50
- Book Value
- 6.72
🔄 Recent Splits
1-for-4
May 3, 2024
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About CSCI
Articles Featuring CSCI.TO
Latest articles and analysis covering CSCI.TO
Why COSCIENS Biopharma Inc. stock is tanking today
COSCIENS Biopharma Inc. experienced a 1.54% drop in stock price today, closing at CA$3.19. This decline highlights ongoing investor concerns regarding the company's restructuring efforts and financial stability.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. experienced a notable stock surge today, closing at CA$3.24, a 7.28% increase. This rise is indicative of investor optimism surrounding the company's ongoing restructuring and strategic initiatives.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has experienced a notable increase of 7.28% in today's trading session, raising questions about the factors driving this positive momentum in the stock market.
Why COSCIENS Biopharma Inc. stock is plummeting today
COSCIENS Biopharma Inc. (CSCI.TO) has seen a significant drop in its stock price, closing down 5.40% at CA$2.98. This decline raises concerns about the company's stability and future prospects.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has surged by over 10% in one trading day, closing at CA$3.15. This increase reflects growing investor confidence following the company's strategic restructuring efforts and favorable financial results.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has experienced a significant one-day gain of 7.81%, closing at CA$2.90. This surge reflects investor optimism amidst the company's ongoing restructuring efforts and strategic initiatives.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. shares surged by over 5% today, closing at CA$2.69. This rise may signal a shift in market sentiment as investors anticipate positive developments for the company.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has seen its stock price rise by over 11% in the last trading session, closing at CA$2.85. This increase is fueled by strong financial results and strategic initiatives aimed at improving operational efficiency.
This Biopharma Stock Could Be 2025’s Biggest Comeback Story
About COSCIENS Biopharma (TSX:CSCI) COSCIENS Biopharma (TSX:CSCI)., headquartered in Toronto, Canada, is a specialty biopharmaceutical company focused on developing and commercializing therapeutics and diagnostic tests. Operating across Canada, Switzerland, Ireland, Denmark, Germany, and the U.S., C
